The Claim
Oxidized eicosapentaenoic acid (EPA) activates peroxisome proliferator-activated receptor alpha (PPARα) in human endothelial cells with greater potency than native EPA, and this activation is necessary for the inhibition of leukocyte adhesion receptor expression during inflammation.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Oxidized EPA directly activates PPARα in human blood vessel cells more strongly than unmodified EPA, and this activation is required to reduce the expression of molecules that attract white blood cells during inflammation.
See the scientific wording
Oxidized eicosapentaenoic acid (EPA) activates peroxisome proliferator-activated receptor alpha (PPARα) in human endothelial cells with greater potency than native EPA, and this activation is necessary for the inhibition of leukocyte adhesion receptor expression during inflammation.
When EPA is oxidized, it enters blood vessel cells and turns on a specific switch called PPARα. This switch blocks another signal that normally tells the cells to make sticky proteins. Without those sticky proteins, white blood cells cannot attach to the vessel walls, preventing inflammation at the site.
What the research says
1 studyWhen EPA gets oxidized (like when it’s exposed to air), it becomes much better at turning on a cellular switch called PPARα, which tells blood vessel cells to stop attracting white blood cells — something native (unoxidized) EPA can’t do well.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.